| abstract |
The present invention relates to the field of Neisseria immunogenic compositions and vaccines, their production and use of such compositions in medicine. In order to overcome the problem of immune response to fHbp that is specific to the meningococci induced fHbp, a chimeric fHbp (factor H binding protein) protein and a composition comprising said protein were described. [Selection figure] None |